Houston, TX, June 02, 2022 (GLOBE NEWSWIRE) -- NuProbe Global, a genomics and molecular diagnostics company, announces the close of its $50M fundraising, co-led by AstraZeneca-CICC Fund, CR-CP Life Science...
We sometimes use our own capital to make strategic investments in companies that fall outside the scope of interest of our managed funds. We also invest selectively in funds managed by other firms with which we have close relationships. With such investments, we target situations where our expertise and industry relationships can meaningfully impact the odds of success. We especially like opportunities where our team members can be involved in the earliest phases of a company’s life. A few examples are listed below.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.